A Vision for a
Life Sciences & Biotechnology Strategy
READ MORE
EUROPABIO MANIFESTO
Unleashing the full potential of Life Sciences and Biotechnology in Europe
EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term.
As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.
The John Sime Award for the best innovation presentation delivered at EFIB 2019 was granted to Guillaume Daoulas, Head of Strategic Marketing at Ÿnsect. In the exhibition, a new area was featuring 20 academic posters. The prize of the best academic poster was awarded to Thomas Gassler from the University of Natural Resources and Life Sciences, Vienna.
As the new European Institutions draw up political guidelines and goals to address climate and sustainability challenges, this year’s conference will highlight the sector’s latest achievements and the potential of a circular bioeconomy for Europe.
As the Association representing the European biotechnology industry, EuropaBio is fully committed to the development of a legislative environment which facilitates the creation of EU jobs and growth as well as new solutions to healthcare challenges.
As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.
As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.